2,406 Shares in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Bought by Parallel Advisors LLC

Share on StockTwits

Parallel Advisors LLC purchased a new stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,406 shares of the software maker’s stock, valued at approximately $28,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. ETF Managers Group LLC raised its stake in shares of Allscripts Healthcare Solutions by 9.7% in the 1st quarter. ETF Managers Group LLC now owns 11,589 shares of the software maker’s stock valued at $111,000 after purchasing an additional 1,028 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Allscripts Healthcare Solutions by 16.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,460 shares of the software maker’s stock valued at $145,000 after purchasing an additional 1,800 shares during the period. Texas Permanent School Fund raised its stake in shares of Allscripts Healthcare Solutions by 1.8% in the 1st quarter. Texas Permanent School Fund now owns 116,332 shares of the software maker’s stock valued at $1,110,000 after purchasing an additional 2,001 shares during the period. Creative Planning raised its stake in shares of Allscripts Healthcare Solutions by 11.9% in the 2nd quarter. Creative Planning now owns 23,103 shares of the software maker’s stock valued at $269,000 after purchasing an additional 2,460 shares during the period. Finally, Rhumbline Advisers grew its holdings in shares of Allscripts Healthcare Solutions by 0.6% in the 1st quarter. Rhumbline Advisers now owns 535,370 shares of the software maker’s stock valued at $5,107,000 after acquiring an additional 3,112 shares in the last quarter.

MDRX has been the subject of several analyst reports. Cantor Fitzgerald restated a “hold” rating and issued a $10.00 price objective on shares of Allscripts Healthcare Solutions in a report on Thursday, May 2nd. Robert W. Baird set a $13.00 price objective on Allscripts Healthcare Solutions and gave the company a “buy” rating in a report on Monday, August 12th. TheStreet cut Allscripts Healthcare Solutions from a “c-” rating to a “d+” rating in a report on Tuesday, August 13th. BidaskClub cut Allscripts Healthcare Solutions from a “sell” rating to a “strong sell” rating in a report on Friday, August 9th. Finally, Evercore ISI restated a “hold” rating and issued a $11.50 price objective on shares of Allscripts Healthcare Solutions in a report on Sunday, August 11th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $12.36.

Allscripts Healthcare Solutions stock traded down $0.02 during midday trading on Wednesday, reaching $8.97. 590 shares of the company’s stock were exchanged, compared to its average volume of 2,053,935. Allscripts Healthcare Solutions Inc has a 52 week low of $8.54 and a 52 week high of $14.97. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $1.54 billion, a price-to-earnings ratio of 16.33, a P/E/G ratio of 1.88 and a beta of 1.30. The stock’s 50-day simple moving average is $10.19 and its 200 day simple moving average is $10.38.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 8th. The software maker reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Allscripts Healthcare Solutions had a return on equity of 6.17% and a net margin of 9.85%. The business had revenue of $444.50 million during the quarter, compared to analysts’ expectations of $449.03 million. During the same quarter last year, the company posted $0.18 earnings per share. Allscripts Healthcare Solutions’s quarterly revenue was up .7% on a year-over-year basis. Research analysts forecast that Allscripts Healthcare Solutions Inc will post 0.48 earnings per share for the current year.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Further Reading: Why do analysts give a neutral rating?

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Retail Opportunity Investments  Raised to “Hold” at Zacks Investment Research
Retail Opportunity Investments Raised to “Hold” at Zacks Investment Research
Morgan Stanley Cuts Zillow Group  Price Target to $32.00
Morgan Stanley Cuts Zillow Group Price Target to $32.00
BT Group – CLASS A  Receives Average Recommendation of “Buy” from Analysts
BT Group – CLASS A Receives Average Recommendation of “Buy” from Analysts
Ascendis Pharma A/S  Expected to Announce Quarterly Sales of $1.88 Million
Ascendis Pharma A/S Expected to Announce Quarterly Sales of $1.88 Million
Superloop  Trading Down 3.4%
Superloop Trading Down 3.4%
Vegalab  Shares Up 2.9%
Vegalab Shares Up 2.9%


© 2006-2019 Ticker Report